Roberto Sotolongo, MD
Internal Medicine · Miami, FLNPI 1013166156
Payments from drug & device makers
Across 559 payments — averaging $10,413 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biontech SE$1.2M
- Amgen$1.1M
- Pfizer$593K
- Cipla USA Inc.$547K
- Janssen Research & Development, LLC$431K
- Genentech, Inc.$421K
- plus $1.5M from 16 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biontech SE | 88 | $1,199,015 |
| Amgen | 2 | $1,105,416 |
| Pfizer | 55 | $593,163 |
| Cipla USA Inc. | 112 | $546,834 |
| Janssen Research & Development, LLC | 28 | $430,621 |
| Genentech, Inc. | 61 | $420,850 |
| Hikma Pharmaceuticals USA | 11 | $348,553 |
| Sanofi US Services Inc. | 42 | $305,922 |
| Novavax Inc | 21 | $298,551 |
| Astrazeneca UK Limited | 7 | $202,695 |
| Sanofi | 44 | $86,400 |
| Noven Pharmaceuticals, Inc. | 13 | $85,210 |
| H. Lundbeck A S | 37 | $75,449 |
| Chiesi USA, Inc. | 6 | $52,955 |
| AstraZeneca | 5 | $23,668 |
| Boehringer Ingelheim | 3 | $18,292 |
| Teva Pharmaceuticals USA, Inc. | 5 | $12,232 |
| Boehringer Ingelheim Pharma GmbH & Co.kg | 2 | $8,346 |
| Novartis | 2 | $5,115 |
| Boehringer Ingelheim International GmbH | 11 | $862 |
| Abbott | 3 | $354 |
| La Jolla Pharmaceutical Company | 1 | $122 |
How this compares
$5,820,625 in reported general payments places this provider in the 95th percentile of 8,530 internal medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other internal medicine in Miami
- Mark KutnerMiami$35.7M
- Mercedes Ponce de LeonMiami$6.8M
- Alejandro de la CruzMiami$6.2M
- Enrique PelayoMiami$5.4M
- Renato DominguezMiami$5.2M
- Ramses VegaMiami$4.4M
- Dunia Llapur HernandezMiami$4.3M
- Yaneicy Gonzalez RojasCoral Gables$93.5M
- Juan Carlos RondonHollywood$66.8M
- Jaynier MoyaPembroke Pines$45.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.